Dr. G. Umberto Meduri is Professor of Medicine and Pharmaceutical Sciences at the University of Tennessee Health Science Center. His research spans the pathophysiology and treatment of critical illness, with major contributions across the full translational continuum from mechanistic discovery to clinical implementation.
Key areas of contribution include:
• Diagnostic innovation: Development of protected bronchoalveolar lavage techniques, advancing diagnostic precision and mechanistic understanding of ventilator-associated pneumonia.
• Respiratory support: Pioneering the use of noninvasive ventilation as an alternative to endotracheal intubation, now widely adopted in clinical practice worldwide.
• Inflammation and host response: Defining dysregulated, persistent inflammation as a central determinant of organ dysfunction and outcome in critical illness.
• Molecular mechanisms: Elucidation of NF-κB activation and impaired glucocorticoid receptor alpha (GRα) signaling as key drivers of failed homeostatic regulation.
• Host defense biology: Demonstration of bidirectional interactions between inflammation and bacterial growth, linking immune dysregulation to infection risk.
• Therapeutic advances: Mechanistic and clinical development of glucocorticoid-based strategies to restore homeostatic control and improve outcomes.
• Conceptual advances: Establishment of the glucocorticoid receptor alpha (GRα) as a master regulator of homeostatic corrections, functioning as a central rheosta
Dr. G. Umberto Meduri is Professor of Medicine and Pharmaceutical Sciences at the University of Tennessee Health Science Center. His research spans the pathophysiology and treatment of critical illness, with major contributions across the full translational continuum from mechanistic discovery to clinical implementation.
Key areas of contribution include:
• Diagnostic innovation: Development of protected bronchoalveolar lavage techniques, advancing diagnostic precision and mechanistic understanding of ventilator-associated pneumonia.
• Respiratory support: Pioneering the use of noninvasive ventilation as an alternative to endotracheal intubation, now widely adopted in clinical practice worldwide.
• Inflammation and host response: Defining dysregulated, persistent inflammation as a central determinant of organ dysfunction and outcome in critical illness.
• Molecular mechanisms: Elucidation of NF-κB activation and impaired glucocorticoid receptor alpha (GRα) signaling as key drivers of failed homeostatic regulation.
• Host defense biology: Demonstration of bidirectional interactions between inflammation and bacterial growth, linking immune dysregulation to infection risk.
• Therapeutic advances: Mechanistic and clinical development of glucocorticoid-based strategies to restore homeostatic control and improve outcomes.
• Conceptual advances: Establishment of the glucocorticoid receptor alpha (GRα) as a master regulator of homeostatic corrections, functioning as a central rheosta